Data / Form D filings / Telos Biotech Inc.
Telos Biotech Inc.: Form D filings
Telos Biotech Inc., a biotechnology company in Dallas, TX, filed 2 Form D notices with the SEC between 2020 and 2025. The latest, on December 12, 2025, reports $724,999 sold of a $2.3 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3060 Pegasus Park Dr, Building 6, Dallas, TX, 75247
- Phone
- (469) 328-6859
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815708
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | New notice | $2,250,000 | $724,999 | $1,525,001 | 4 | Dec 1, 2025 | sec.gov |
| Jul 10, 2020 | New notice | $700,000 | $700,000 | 1 | Dec 23, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Enzo Ehsan Tedone | Executive Officer, Director | |
| Mohammad Ehsan Sayed | Executive Officer, Director | |
| Jerry William Shay | Executive Officer | |
| Sebastian Aguiar Brunemeier | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 8, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Telos Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.